Equities

Compugen Ltd

Compugen Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (ILa)635.40
  • Today's Change23.40 / 3.82%
  • Shares traded834.04k
  • 1 Year change+130.05%
  • Beta1.5651
Data delayed at least 20 minutes, as of Nov 07 2024 15:24 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Earnings history & estimates in USD

On Aug 06, 2024, Compugen Ltd reported 2nd quarter 2024 losses of -0.02 per share. This result exceeded the -0.07 consensus loss of the 3 analysts covering the company and exceeded last year's 2nd quarter results by 81.82%.
The next earnings announcement is expected on Mar 03, 2025.
Average growth rate+37.50%
Compugen Ltd reported annual 2023 losses of -0.21 per share on Mar 05, 2024.
Average growth rate+13.54%
More ▼

Revenue history & estimates in USD

Compugen Ltd. had 2nd quarter 2024 revenues of 6.70m. This bettered the 2.49m consensus of the 2 analysts covering the company.
Average growth rate+23.18%
Compugen Ltd. had revenues for the full year 2023 of 33.46m. This was 346.12% above the prior year's results.
Average growth rate+190.37%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.